Radiopharm
Ended Awarded Last action
- Contract number
- 36C25225N0361
- Awardee
-
Jubilant Draximage Radiopharmacies, Inc. UEI ZL79MXYVNDM1
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $200,000
Award facts
- Contract value 100% obligated
- $200,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Norcross, GA, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $200,000 |
About this award
Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, was awarded a $200,000 delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 12 on April 4, 2025. The firm-fixed-price contract, with an ultimate completion date of March 31, 2026, covers the supply of radiopharmaceutical products to support nuclear medicine procedures at VA medical facilities. Performance will be executed in Norcross, Georgia. This award was not designated as a set-aside contract. As a self-certified small disadvantaged business and subsidiary of Jubilant Life Sciences Limited, Jubilant Radiopharma specializes in manufacturing and distributing medical isotopes and diagnostic imaging agents essential for positron emission tomography scans, cardiac imaging, and cancer treatment diagnostics.
This delivery order represents one component of Jubilant Radiopharma's substantial relationship with the VA, which includes multiple Indefinite Delivery Vehicles across nine Veterans Integrated Service Networks with collective potential values exceeding $70 million. These larger vehicles enable the VA to efficiently procure critical radiopharmaceutical products such as fluorodeoxyglucose F-18, iodine-123, iodine-131, technetium-99m, gallium-67 citrate, and indium-111 pentetreotide to support the department's nationwide nuclear medicine capabilities for veteran populations.
Quick answers
Who was awarded contract 36C25225N0361?
36C25225N0361 was awarded to Jubilant Draximage Radiopharmacies, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on April 4, 2025.
How much is contract 36C25225N0361 worth?
The government has obligated $200,000 on 36C25225N0361.
Is contract 36C25225N0361 an order under another contract?
Yes. 36C25225N0361 is a delivery order under 36C25225D0040, an indefinite delivery contract.
Was contract 36C25225N0361 competed?
The extent of competition for 36C25225N0361 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award